Dr. Aileen M. Marty is a physician-scientist, clinician, and anatomic/clinical pathologist whose career spans over 45 years of research, diagnostic innovation, and translational leadership at the intersection of infectious disease pathology, outbreak response, and public health. Her research began in 1976 with work on vision studies in the lemon shark (Negaprion brevirostris) and encompasses many sizeable clinical investigations and pathological research studies involving a wide span of pathogens, from viruses to helminths – including emerging pathogens and pathogens associated with biological terrorism. Of note are her work on viruses (e.g., dengue, Zika, and Mpox), ehrlichiosis (e.g., Ehrlichia chaffeensis), and the interactions between helminthic infections and drug interactions (e.g., Onchocerciasis and Ivermectin studies), clinic-pathological studies on the health impact of vaccines (Venezuela Encephalitis virus) on humans and rodents, epidemiological and laboratory studies on disease (leprosy in humans and non-human primates), and heavy contributions to studies on the pathogenesis of Ebola virus on humans and non-human primates, disease surveillance, and the public health impact of disease including legal, medical, and sociological factors. Overall, her research is characterized by a multidisciplinary approach that includes clinical practice, pathology, epidemiology, economic impacts, and public health policy. It emphasizes the diagnosis, prevention, and management